Company
Zai Lab Ltd (ZLAB)
Standardized SEC financial data for Zai Lab Ltd — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001704292 · NASDAQ · Pharmaceutical Preparations.
Gross margin
59.0%
Operating margin
-50.2%
Net margin
-38.4%
Revenue growth (YoY)
14.6%
Return on equity
-24.5%
Free cash flow
-$158.9M
Current ratio
2.45×
EPS (diluted)
$-0.16
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $49.0M | $144.3M | $215.0M | $266.7M | $399.0M | $460.2M |
| Cost of revenue |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $442.1M | $964.1M | $1.01B | $790.2M | $449.7M | $679.6M |
| Inventory |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$216.1M | -$549.2M | -$367.6M | -$198.2M | -$214.9M | -$150.8M |
| Capital expenditures |
Get ZLAB data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/ZLAB/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/ZLAB/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"